Trial Profile
The effects of aromatase inhibition on sex steroids, pituitary hormones, markers of bone turnover, muscle strength and cognition on older men
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Testosterone (Primary)
- Indications Depression; Diabetes mellitus; Hypogonadism; Muscular atrophy; Osteoporosis
- Focus Therapeutic Use
- 07 Mar 2016 Primary endpoint has been met. (Prostate volume by transrectal ultrasound by in testosterone group), as per an article published in the Journal of Clinical Endocrinology and Metabolism.
- 07 Mar 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
- 01 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.